In an era where health information is often overwhelming and contradictory, HT Lifestyle has launched a reader-centric initiative: HT Health Talk. Every week, we invite readers to share their most ...

Mark Guiducci is the global editorial director of Vanity Fair, overseeing the creative and editorial direction of the brand across all markets where it is published, including the United States, ...

Ask a Doctor is a series of physician-authored columns offering insights and advice on common health topics. It is not a substitute for seeking medical care. If your sexual desire has changed or ...

Lana Condor joins our video call fresh off a blur of travel and jet lag. She’s just wrapped a press tour for her latest movie, “Pretty Lethal,” and is anxiously awaiting the release of Netflix’s “XO, ...

March 19 (Reuters) - British defence contractor BAE Systems (BAES.L), opens new tab will sell its remaining stake in ‌Kazakhstan's Air Astana (AIRA.KZ), opens new tab, the Kazakh company said on ...

UK aerospace firm BAE Systems is selling its remaining interest in Kazakh operator Air Astana Group, divesting the entire shareholding, nearly 6.9%, to institutional investors. BAE Systems was a ...

See more of our trusted coverage when you search. Prefer Newsweek on Google to see more of our trusted coverage when you search. Women have less desire for sex—because of hormones, evolution, ...

The FDA approved Addyi, the first pill for low libido in women, boosting sexual desire. A Paramount+ documentary follows Cindy Eckert's campaign for FDA approval off Addyi Addyi improves sexual ...

This is read by an automated voice. Please report any issues or inconsistencies here. For most women, the shift doesn’t arrive all at once. It builds. Not dramatic enough to name immediately. Not ...

Every day, the most powerful and influential people in the most powerful and influential city on earth read the New York Post. Founded in 1801 by Alexander Hamilton, the New York Post has been telling ...

Share on Pinterest The FDA has expanded its approval of a libido-boosting drug to postmenopausal women. Xvision/Getty Images On December 15, 2025, the U.S. FDA approved Addyi (flibanserin) for the ...